Gender differences in SUD treatment: Recent findings from the Clinical Trials Network. (CTN Gender Special Interest Group meeting)
This symposium presented findings from the National Drug Abuse Treatment Clinical Trials Network focused on gender differences in four different studies: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12, CTN-0031); Web Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders (CTN-0044); Screening, Motivational Assessment, Referral and Treatment in Emergency Departments (SMART-ED, CTN-0047); and Stimulant Reduction Intervention Using Dosed Exercise (STRIDE, CTN-0037).
Presentations included:
Elizabeth A. Wells, PhD, University of Washington
Gender Differences in Response to a 12 Step Engagement Intervention.
Aimee N.C. Campbell, PhD, MSW, Columbia University in the City of New York
Gender Differences in Acceptability and Treatment Outcomes of a Web Based Psychosocial Intervention.
Audrey Brooks, PhD, University of Arizona
Gender Differences in Treatment Access and Outcome Following an ED SBIRT Intervention.
Therese K. Killeen, PhD, Medical University of South Carolina
Stimulant Reduction Intervention Using Dosed Exercise: Gender Differences/Treatment Acceptability.
Discussant: Shelly F. Greenfield, MD, MPH, Harvard Medical School
Related protocols: CTN-0031, CTN-0037, CTN-0044, CTN-0047